Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul P Tak

Showing results (41-50 of 308) with videos related to

Pageof 31
Sort By:
Autoimmunity Reviews|April 19, 2011
Inflammatory memories: is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis?Caroline Ospelt, Kris A Reedquist, Steffen Gay, et al.
Annals of the Rheumatic Diseases|September 29, 2011
Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decayAleksander M Grabiec, Olexandr Korchynskyi, Paul P Tak, et al.
Arthritis and Rheumatism|November 28, 2008
Disease activity-guided rituximab therapy in rheumatoid arthritis: the effects of re-treatment in initial nonresponders versus initial respondersRogier M Thurlings, Koen Vos, Daniëlle M Gerlag, et al.
Arthritis and Rheumatism|February 1, 2011
Body mass index and clinical response to infliximab in rheumatoid arthritisRuth Klaasen, Carla A Wijbrandts, Danielle M Gerlag, et al.
Current Gene Therapy|June 13, 2009
Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancerSander W Tas, Margriet J B M Vervoordeldonk, Paul P Tak
Nederlands Tijdschrift Voor Geneeskunde|November 17, 2011
[Tailored therapy for rheumatic disease within reach]Lisa G M van Baarsen, Beatrijs M Lodde, Paul P Tak
Nature Reviews. Drug Discovery|November 4, 2016
Epigenetic drug discovery: breaking through the immune barrierDavid F Tough, Paul P Tak, Alexander Tarakhovsky, et al.
Arthritis and Rheumatism|March 4, 2008
The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammationBernard Vandooren, Tineke Cantaert, Troy Noordenbos, et al.
Nature Reviews. Rheumatology|May 10, 2019
Therapeutic options for targeting inflammatory osteoarthritis painPhilip G Conaghan, Andrew D Cook, John A Hamilton, et al.
The Journal of Rheumatology|April 17, 2015
Summary of Sensitivity and Specificity for Psoriatic Arthritis in a South African Cohort according to Classification CriteriaAjesh B Maharaj, Jayandran Govender, Kasthurba Maharaj, et al.
Pageof 31

Showing results (41-50 of 308) with videos related to

Sort By:
Pageof 31
Autoimmunity Reviews|April 19, 2011
Inflammatory memories: is epigenetics the missing link to persistent stromal cell activation in rheumatoid arthritis?Caroline Ospelt, Kris A Reedquist, Steffen Gay, et al.
Annals of the Rheumatic Diseases|September 29, 2011
Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decayAleksander M Grabiec, Olexandr Korchynskyi, Paul P Tak, et al.
Arthritis and Rheumatism|November 28, 2008
Disease activity-guided rituximab therapy in rheumatoid arthritis: the effects of re-treatment in initial nonresponders versus initial respondersRogier M Thurlings, Koen Vos, Daniëlle M Gerlag, et al.
Arthritis and Rheumatism|February 1, 2011
Body mass index and clinical response to infliximab in rheumatoid arthritisRuth Klaasen, Carla A Wijbrandts, Danielle M Gerlag, et al.
Current Gene Therapy|June 13, 2009
Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancerSander W Tas, Margriet J B M Vervoordeldonk, Paul P Tak
Nederlands Tijdschrift Voor Geneeskunde|November 17, 2011
[Tailored therapy for rheumatic disease within reach]Lisa G M van Baarsen, Beatrijs M Lodde, Paul P Tak
Nature Reviews. Drug Discovery|November 4, 2016
Epigenetic drug discovery: breaking through the immune barrierDavid F Tough, Paul P Tak, Alexander Tarakhovsky, et al.
Arthritis and Rheumatism|March 4, 2008
The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammationBernard Vandooren, Tineke Cantaert, Troy Noordenbos, et al.
Nature Reviews. Rheumatology|May 10, 2019
Therapeutic options for targeting inflammatory osteoarthritis painPhilip G Conaghan, Andrew D Cook, John A Hamilton, et al.
The Journal of Rheumatology|April 17, 2015
Summary of Sensitivity and Specificity for Psoriatic Arthritis in a South African Cohort according to Classification CriteriaAjesh B Maharaj, Jayandran Govender, Kasthurba Maharaj, et al.
Pageof 31